Industry Research Reports

Home > Reports > Pharma & Healthcare > Platinum-based Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Platinum-based Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-02-19

Pages: 141 Pages

Report ld: 2528302

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Platinum-based Anticancer Drugs was estimated to be worth US$ 1541.9 million in 2023 and is forecast to a readjusted size of US$ 1788.9 million by 2030 with a CAGR of 2.1% during the forecast period 2024-2030
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Platinum-based Anticancer Drugs Market Size

M= millions and B=billions

Report Scope
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Platinum-based Anticancer Drugs by region & country, by Type, and by Application.

The Platinum-based Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer Drugs.

Market Segmentation

Report Metric
Details
Report Title
Platinum-based Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1788.9 million
CAGR(2024-2030)
2.1%
Market Size Available for Years
2019-2030
Global Platinum-based Anticancer Drugs Companies Covered
Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira(Pfizer), Mylan, Taj Pharmaceuticals, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Luoxin, Lingnan Pharmacy, Hansoh Pharma
Global Platinum-based Anticancer Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Platinum-based Anticancer Drugs Market, Segment by Type
Cisplatin

Carboplatin

Oxaliplatin

Nedaplatin

Others
Global Platinum-based Anticancer Drugs Market, Segment by Application
Testicular Cancer

Osteosarcoma

Breast Cancer

Esophageal Cancer

NSCLC

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Platinum-based Anticancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Platinum-based Anticancer Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Platinum-based Anticancer Drugs Product Introduction
    1.2 Global Platinum-based Anticancer Drugs Market Size Forecast
        1.2.1 Global Platinum-based Anticancer Drugs Sales Value (2019-2030)
        1.2.2 Global Platinum-based Anticancer Drugs Sales Volume (2019-2030)
        1.2.3 Global Platinum-based Anticancer Drugs Sales Price (2019-2030)
    1.3 Platinum-based Anticancer Drugs Market Trends & Drivers
        1.3.1 Platinum-based Anticancer Drugs Industry Trends
        1.3.2 Platinum-based Anticancer Drugs Market Drivers & Opportunity
        1.3.3 Platinum-based Anticancer Drugs Market Challenges
        1.3.4 Platinum-based Anticancer Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Platinum-based Anticancer Drugs Players Revenue Ranking (2023)
    2.2 Global Platinum-based Anticancer Drugs Revenue by Company (2019-2024)
    2.3 Global Platinum-based Anticancer Drugs Players Sales Volume Ranking (2023)
    2.4 Global Platinum-based Anticancer Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Platinum-based Anticancer Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Platinum-based Anticancer Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Platinum-based Anticancer Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Platinum-based Anticancer Drugs
    2.9 Platinum-based Anticancer Drugs Market Competitive Analysis
        2.9.1 Platinum-based Anticancer Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Platinum-based Anticancer Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Cisplatin
        3.1.2 Carboplatin
        3.1.3 Oxaliplatin
        3.1.4 Nedaplatin
        3.1.5 Others
    3.2 Global Platinum-based Anticancer Drugs Sales Value by Type
        3.2.1 Global Platinum-based Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Platinum-based Anticancer Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Platinum-based Anticancer Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Platinum-based Anticancer Drugs Sales Volume by Type
        3.3.1 Global Platinum-based Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Platinum-based Anticancer Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Platinum-based Anticancer Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Platinum-based Anticancer Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Testicular Cancer
        4.1.2 Osteosarcoma
        4.1.3 Breast Cancer
        4.1.4 Esophageal Cancer
        4.1.5 NSCLC
        4.1.6 Other
    4.2 Global Platinum-based Anticancer Drugs Sales Value by Application
        4.2.1 Global Platinum-based Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Platinum-based Anticancer Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Platinum-based Anticancer Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Platinum-based Anticancer Drugs Sales Volume by Application
        4.3.1 Global Platinum-based Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Platinum-based Anticancer Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Platinum-based Anticancer Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Platinum-based Anticancer Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Platinum-based Anticancer Drugs Sales Value by Region
        5.1.1 Global Platinum-based Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Platinum-based Anticancer Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Platinum-based Anticancer Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Platinum-based Anticancer Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Platinum-based Anticancer Drugs Sales Volume by Region
        5.2.1 Global Platinum-based Anticancer Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Platinum-based Anticancer Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Platinum-based Anticancer Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Platinum-based Anticancer Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Platinum-based Anticancer Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Platinum-based Anticancer Drugs Sales Value, 2019-2030
        5.4.2 North America Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Platinum-based Anticancer Drugs Sales Value, 2019-2030
        5.5.2 Europe Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Platinum-based Anticancer Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Platinum-based Anticancer Drugs Sales Value, 2019-2030
        5.7.2 South America Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Platinum-based Anticancer Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Platinum-based Anticancer Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Platinum-based Anticancer Drugs Sales Value
        6.2.1 Key Countries/Regions Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.3.2 United States Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.4.2 Europe Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.5.2 China Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.6.2 Japan Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.7.2 South Korea Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Platinum-based Anticancer Drugs Sales Value, 2019-2030
        6.9.2 India Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Platinum-based Anticancer Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Sanofi-Aventis
        7.1.1 Sanofi-Aventis Company Information
        7.1.2 Sanofi-Aventis Introduction and Business Overview
        7.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Sanofi-Aventis Platinum-based Anticancer Drugs Product Offerings
        7.1.5 Sanofi-Aventis Recent Development
    7.2 Yakult honsha
        7.2.1 Yakult honsha Company Information
        7.2.2 Yakult honsha Introduction and Business Overview
        7.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Yakult honsha Platinum-based Anticancer Drugs Product Offerings
        7.2.5 Yakult honsha Recent Development
    7.3 Dr Reddy's laboratories
        7.3.1 Dr Reddy's laboratories Company Information
        7.3.2 Dr Reddy's laboratories Introduction and Business Overview
        7.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offerings
        7.3.5 Dr Reddy's laboratories Recent Development
    7.4 Sun Pharmaceutical
        7.4.1 Sun Pharmaceutical Company Information
        7.4.2 Sun Pharmaceutical Introduction and Business Overview
        7.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
        7.4.5 Sun Pharmaceutical Recent Development
    7.5 Teva
        7.5.1 Teva Company Information
        7.5.2 Teva Introduction and Business Overview
        7.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Teva Platinum-based Anticancer Drugs Product Offerings
        7.5.5 Teva Recent Development
    7.6 Fresenius Kabi
        7.6.1 Fresenius Kabi Company Information
        7.6.2 Fresenius Kabi Introduction and Business Overview
        7.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Fresenius Kabi Platinum-based Anticancer Drugs Product Offerings
        7.6.5 Fresenius Kabi Recent Development
    7.7 Hospira(Pfizer)
        7.7.1 Hospira(Pfizer) Company Information
        7.7.2 Hospira(Pfizer) Introduction and Business Overview
        7.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offerings
        7.7.5 Hospira(Pfizer) Recent Development
    7.8 Mylan
        7.8.1 Mylan Company Information
        7.8.2 Mylan Introduction and Business Overview
        7.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Mylan Platinum-based Anticancer Drugs Product Offerings
        7.8.5 Mylan Recent Development
    7.9 Taj Pharmaceuticals
        7.9.1 Taj Pharmaceuticals Company Information
        7.9.2 Taj Pharmaceuticals Introduction and Business Overview
        7.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offerings
        7.9.5 Taj Pharmaceuticals Recent Development
    7.10 Jiangsu Hengrui Medicine
        7.10.1 Jiangsu Hengrui Medicine Company Information
        7.10.2 Jiangsu Hengrui Medicine Introduction and Business Overview
        7.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offerings
        7.10.5 Jiangsu Hengrui Medicine Recent Development
    7.11 Nanjing Pharmaceutical Factory
        7.11.1 Nanjing Pharmaceutical Factory Company Information
        7.11.2 Nanjing Pharmaceutical Factory Introduction and Business Overview
        7.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offerings
        7.11.5 Nanjing Pharmaceutical Factory Recent Development
    7.12 Jiangsu Aosaikang Pharmaceutical
        7.12.1 Jiangsu Aosaikang Pharmaceutical Company Information
        7.12.2 Jiangsu Aosaikang Pharmaceutical Introduction and Business Overview
        7.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
        7.12.5 Jiangsu Aosaikang Pharmaceutical Recent Development
    7.13 Qilu Pharmaceutical
        7.13.1 Qilu Pharmaceutical Company Information
        7.13.2 Qilu Pharmaceutical Introduction and Business Overview
        7.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
        7.13.5 Qilu Pharmaceutical Recent Development
    7.14 Hisun Pharmaceutical
        7.14.1 Hisun Pharmaceutical Company Information
        7.14.2 Hisun Pharmaceutical Introduction and Business Overview
        7.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
        7.14.5 Hisun Pharmaceutical Recent Development
    7.15 Luoxin
        7.15.1 Luoxin Company Information
        7.15.2 Luoxin Introduction and Business Overview
        7.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Luoxin Platinum-based Anticancer Drugs Product Offerings
        7.15.5 Luoxin Recent Development
    7.16 Lingnan Pharmacy
        7.16.1 Lingnan Pharmacy Company Information
        7.16.2 Lingnan Pharmacy Introduction and Business Overview
        7.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offerings
        7.16.5 Lingnan Pharmacy Recent Development
    7.17 Hansoh Pharma
        7.17.1 Hansoh Pharma Company Information
        7.17.2 Hansoh Pharma Introduction and Business Overview
        7.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Hansoh Pharma Platinum-based Anticancer Drugs Product Offerings
        7.17.5 Hansoh Pharma Recent Development

 8 Industry Chain Analysis
    8.1 Platinum-based Anticancer Drugs Industrial Chain
    8.2 Platinum-based Anticancer Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Platinum-based Anticancer Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Platinum-based Anticancer Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Platinum-based Anticancer Drugs Market Trends
    Table 2. Platinum-based Anticancer Drugs Market Drivers & Opportunity
    Table 3. Platinum-based Anticancer Drugs Market Challenges
    Table 4. Platinum-based Anticancer Drugs Market Restraints
    Table 5. Global Platinum-based Anticancer Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Platinum-based Anticancer Drugs Sales Volume by Company (2019-2024) & (MT)
    Table 8. Global Platinum-based Anticancer Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Platinum-based Anticancer Drugs Price by Company (2019-2024) & (US$/MT)
    Table 10. Key Manufacturers Platinum-based Anticancer Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Platinum-based Anticancer Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Platinum-based Anticancer Drugs
    Table 13. Global Platinum-based Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Platinum-based Anticancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Platinum-based Anticancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Platinum-based Anticancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Platinum-based Anticancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
    Table 22. Global Platinum-based Anticancer Drugs Sales Volume by Type (2019-2024) & (MT)
    Table 23. Global Platinum-based Anticancer Drugs Sales Volume by Type (2025-2030) & (MT)
    Table 24. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Platinum-based Anticancer Drugs Price by Type (2019-2024) & (US$/MT)
    Table 27. Global Platinum-based Anticancer Drugs Price by Type (2025-2030) & (US$/MT)
    Table 28. Global Platinum-based Anticancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Platinum-based Anticancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Platinum-based Anticancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Platinum-based Anticancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
    Table 34. Global Platinum-based Anticancer Drugs Sales Volume by Application (2019-2024) & (MT)
    Table 35. Global Platinum-based Anticancer Drugs Sales Volume by Application (2025-2030) & (MT)
    Table 36. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Platinum-based Anticancer Drugs Price by Application (2019-2024) & (US$/MT)
    Table 39. Global Platinum-based Anticancer Drugs Price by Application (2025-2030) & (US$/MT)
    Table 40. Global Platinum-based Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Platinum-based Anticancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Platinum-based Anticancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Platinum-based Anticancer Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Platinum-based Anticancer Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Platinum-based Anticancer Drugs Sales Volume by Region (MT): 2019 VS 2023 VS 2030
    Table 46. Global Platinum-based Anticancer Drugs Sales Volume by Region (2019-2024) & (MT)
    Table 47. Global Platinum-based Anticancer Drugs Sales Volume by Region (2025-2030) & (MT)
    Table 48. Global Platinum-based Anticancer Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Platinum-based Anticancer Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Platinum-based Anticancer Drugs Average Price by Region (2019-2024) & (US$/MT)
    Table 51. Global Platinum-based Anticancer Drugs Average Price by Region (2025-2030) & (US$/MT)
    Table 52. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume, (2019-2024) & (MT)
    Table 56. Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume, (2025-2030) & (MT)
    Table 57. Sanofi-Aventis Company Information
    Table 58. Sanofi-Aventis Introduction and Business Overview
    Table 59. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 60. Sanofi-Aventis Platinum-based Anticancer Drugs Product Offerings
    Table 61. Sanofi-Aventis Recent Development
    Table 62. Yakult honsha Company Information
    Table 63. Yakult honsha Introduction and Business Overview
    Table 64. Yakult honsha Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 65. Yakult honsha Platinum-based Anticancer Drugs Product Offerings
    Table 66. Yakult honsha Recent Development
    Table 67. Dr Reddy's laboratories Company Information
    Table 68. Dr Reddy's laboratories Introduction and Business Overview
    Table 69. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 70. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offerings
    Table 71. Dr Reddy's laboratories Recent Development
    Table 72. Sun Pharmaceutical Company Information
    Table 73. Sun Pharmaceutical Introduction and Business Overview
    Table 74. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 75. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
    Table 76. Sun Pharmaceutical Recent Development
    Table 77. Teva Company Information
    Table 78. Teva Introduction and Business Overview
    Table 79. Teva Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 80. Teva Platinum-based Anticancer Drugs Product Offerings
    Table 81. Teva Recent Development
    Table 82. Fresenius Kabi Company Information
    Table 83. Fresenius Kabi Introduction and Business Overview
    Table 84. Fresenius Kabi Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 85. Fresenius Kabi Platinum-based Anticancer Drugs Product Offerings
    Table 86. Fresenius Kabi Recent Development
    Table 87. Hospira(Pfizer) Company Information
    Table 88. Hospira(Pfizer) Introduction and Business Overview
    Table 89. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 90. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offerings
    Table 91. Hospira(Pfizer) Recent Development
    Table 92. Mylan Company Information
    Table 93. Mylan Introduction and Business Overview
    Table 94. Mylan Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 95. Mylan Platinum-based Anticancer Drugs Product Offerings
    Table 96. Mylan Recent Development
    Table 97. Taj Pharmaceuticals Company Information
    Table 98. Taj Pharmaceuticals Introduction and Business Overview
    Table 99. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 100. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offerings
    Table 101. Taj Pharmaceuticals Recent Development
    Table 102. Jiangsu Hengrui Medicine Company Information
    Table 103. Jiangsu Hengrui Medicine Introduction and Business Overview
    Table 104. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 105. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offerings
    Table 106. Jiangsu Hengrui Medicine Recent Development
    Table 107. Nanjing Pharmaceutical Factory Company Information
    Table 108. Nanjing Pharmaceutical Factory Introduction and Business Overview
    Table 109. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 110. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offerings
    Table 111. Nanjing Pharmaceutical Factory Recent Development
    Table 112. Jiangsu Aosaikang Pharmaceutical Company Information
    Table 113. Jiangsu Aosaikang Pharmaceutical Introduction and Business Overview
    Table 114. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 115. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
    Table 116. Jiangsu Aosaikang Pharmaceutical Recent Development
    Table 117. Qilu Pharmaceutical Company Information
    Table 118. Qilu Pharmaceutical Introduction and Business Overview
    Table 119. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 120. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
    Table 121. Qilu Pharmaceutical Recent Development
    Table 122. Hisun Pharmaceutical Company Information
    Table 123. Hisun Pharmaceutical Introduction and Business Overview
    Table 124. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 125. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
    Table 126. Hisun Pharmaceutical Recent Development
    Table 127. Luoxin Company Information
    Table 128. Luoxin Introduction and Business Overview
    Table 129. Luoxin Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 130. Luoxin Platinum-based Anticancer Drugs Product Offerings
    Table 131. Luoxin Recent Development
    Table 132. Lingnan Pharmacy Company Information
    Table 133. Lingnan Pharmacy Introduction and Business Overview
    Table 134. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 135. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offerings
    Table 136. Lingnan Pharmacy Recent Development
    Table 137. Hansoh Pharma Company Information
    Table 138. Hansoh Pharma Introduction and Business Overview
    Table 139. Hansoh Pharma Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 140. Hansoh Pharma Platinum-based Anticancer Drugs Product Offerings
    Table 141. Hansoh Pharma Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Platinum-based Anticancer Drugs Downstream Customers
    Table 145. Platinum-based Anticancer Drugs Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Platinum-based Anticancer Drugs Product Picture
    Figure 2. Global Platinum-based Anticancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Platinum-based Anticancer Drugs Sales Volume (2019-2030) & (MT)
    Figure 5. Global Platinum-based Anticancer Drugs Sales Price (2019-2030) & (US$/MT)
    Figure 6. Platinum-based Anticancer Drugs Report Years Considered
    Figure 7. Global Platinum-based Anticancer Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Platinum-based Anticancer Drugs Players Sales Volume Ranking (2023) & (MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Platinum-based Anticancer Drugs Revenue in 2023
    Figure 10. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Cisplatin Picture
    Figure 12. Carboplatin Picture
    Figure 13. Oxaliplatin Picture
    Figure 14. Nedaplatin Picture
    Figure 15. Others Picture
    Figure 16. Global Platinum-based Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Platinum-based Anticancer Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Platinum-based Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
    Figure 19. Global Platinum-based Anticancer Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Platinum-based Anticancer Drugs Price by Type (2019-2030) & (US$/MT)
    Figure 21. Product Picture of Testicular Cancer
    Figure 22. Product Picture of Osteosarcoma
    Figure 23. Product Picture of Breast Cancer
    Figure 24. Product Picture of Esophageal Cancer
    Figure 25. Product Picture of NSCLC
    Figure 26. Product Picture of Other
    Figure 27. Global Platinum-based Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 28. Global Platinum-based Anticancer Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 29. Global Platinum-based Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
    Figure 30. Global Platinum-based Anticancer Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 31. Global Platinum-based Anticancer Drugs Price by Application (2019-2030) & (US$/MT)
    Figure 32. North America Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. North America Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. Europe Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. Europe Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Asia Pacific Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. South America Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 39. South America Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 40. Middle East & Africa Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 42. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value (%), (2019-2030)
    Figure 43. Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume (%), (2019-2030)
    Figure 44. United States Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 45. United States Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 46. United States Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 47. Europe Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Europe Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 49. Europe Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 50. China Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 51. China Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 52. China Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 53. Japan Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Japan Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 55. Japan Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 56. South Korea Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 57. South Korea Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 58. South Korea Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 59. Southeast Asia Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 60. Southeast Asia Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 61. Southeast Asia Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 62. India Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 63. India Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 64. India Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 65. Platinum-based Anticancer Drugs Industrial Chain
    Figure 66. Platinum-based Anticancer Drugs Manufacturing Cost Structure
    Figure 67. Channels of Distribution (Direct Sales, and Distribution)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed

Description

The global market for Platinum-based Anticancer Drugs was estimated to be worth US$ 1541.9 million in 2023 and is forecast to a readjusted size of US$ 1788.9 million by 2030 with a CAGR of 2.1% during the forecast period 2024-2030
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Platinum-based Anticancer Drugs by region & country, by Type, and by Application.

The Platinum-based Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer Drugs.

Market Segmentation